Kristin VanderPas' practice focuses on public and private security offerings. She has represented both issuers and investment banks in a variety of equity and debt transactions, including initial public offerings, secondary offerings of common stock and convertible note offerings. Kristin is also a market leader in SPAC M&A transactions, representing both target companies and investors in the de-SPAC process in transactions ranging in value up to $5 billion. Kristin also counsels clients in general corporate and securities law matters.
Download full bio
LumiraDx Limited – $100.3 Million Follow-on Offering and Concurrent Private Placement
Pliant Therapeutics – $230.0 Million Follow-on Offering
Arcutis Biotherapeutics – $172.5 Million Follow-on Offering
Crinetics Pharmaceuticals – $125 Million Follow-On Offering
Zymeworks – $115 Million Follow-On Offering
Kristin VanderPas has a strong client base of leading investment banks and companies in the tech and life sciences sectors.
University of Southern California Gould School of LawJD, 2009
University of North Carolina at Chapel HillBSBA , Business Administration 2006
Lavoro to Become Publicly Traded Through Business Combination With TPB Acquisition Corporation I
September 20, 2022
Chambers USA 2022 Recognizes Cooley Lawyers + Practices
June 2, 2022
Grindr Agrees to Merge With SPAC Tiga Acquisition Corp.
May 10, 2022
Chambers USA: Up and Coming – Capital Markets: Debt & Equity (California and Nationwide – Western United States) (2021-2022)
Daily Journal: Top 40 Under 40 (2019)
+1 415 693 2097